Chicago Equity Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$1.45M Buy
39,485
+19,540
+98% +$759K 0.15% 209
2019
Q4
$808K Hold
19,945
0.05% 516
2019
Q3
$692K Sell
19,945
-29,185
-59% -$961K 0.03% 598
2019
Q2
$1.56M Buy
49,130
+17,605
+56% +$523K 0.07% 400
2019
Q1
$943K Sell
31,525
-825
-3% -$23.6K 0.04% 524
2018
Q4
$999K Buy
+32,350
New +$1.18M 0.04% 493

Other funds holding PBH

Chicago Equity Partners's PBH Position: Q1 2020 in Review

Chicago Equity Partners increased its Prestige Consumer Healthcare (PBH) stake by 98% in Q1 2020, buying an estimated $759K and bringing the position to 39,485 shares worth $1.45M. The position accounts for 0.15% of the portfolio, ranked #209.

Chicago Equity Partners first reported a position in PBH in Q4 2018 and has held it in 6 quarters since. The position peaked at $1.56M in Q2 2019. 251 funds tracked by Wall St. Rank hold PBH as of Q1 2020.

  • Chicago Equity Partners held 39,485 shares of Prestige Consumer Healthcare worth $1.45M as of Q1 2020.
  • Chicago Equity Partners bought 19,540 Prestige Consumer Healthcare shares in Q1 2020, an estimated $759K.
  • Prestige Consumer Healthcare made up 0.15% of Chicago Equity Partners's portfolio in Q1 2020, its #209 holding.
  • Chicago Equity Partners first reported a position in Prestige Consumer Healthcare in Q4 2018 and has held it in 6 quarters since.
  • Chicago Equity Partners's Prestige Consumer Healthcare position peaked at $1.56M in Q2 2019.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.